Value communication

Home
Value communication

Services

Value Communication Strategy and Execution.

Aim to devise and execute effectively, an evidence synthesis and communication strategy that will support optimal product price, market access and commercialisation.
Such a strategy, is based on data synthesised with vigorous methodologies, to yield compelling evidence, that will demonstrate to different decision makers, convincingly meaningful, relevant and customised unmet need and incremental product value attained by the system stakeholders, such patients, payers, providers, so as to attain positive appraisals, reimbursement and coverage decisions.

Our 5 Steps Process for Value Communication

Critical Client Task

Regulations: Monitor, understand and foresee evolution of pricing and access landscape; identify data and evidential requirements; understand success factors, challenges and opportunities at national and subnational level.
Market : Monitor, analyse and foresee competitors and their tactics; Assess competitive landscape; Benchmark and assess strengths, weaknesses, opportunities and risks.
Products: Understand disease, management pathways and therapy dynamics; assess therapeutic alternatives; reveal unmet patient, provider and payer needs; foresee technology and epidemiology trends.
Stakeholders: Identify important stakeholders for pricing and reimbursement and foresee their agendas, priorities, thinking, evidential requirements, and needs at national and subnational level.

Services We Provide

Regulations : Assess pricing and market access (P&R, HTA) landscape; develop intelligence and strategic insights; reveal critical pathways drivers and limiters; reviews, stakeholders surveys, advisory boards, delphi panels and workshops.
Market: Asses competitive and market landscape; Collect intelligence, analyse and develop insights; Undertake benchmarking; Assess opportunities and risks.
Products: Undertake rapid, targeted or systematic reviews of disease, patient management practice, and medical technology, through desktop research, stakeholder surveys, advisory boards and workshops.
Stakeholders: Map stakeholders and influence dynamics; develop intelligence and insights; analyse needs, product perceptions and value drivers; segment payers and providers; evaluate opportunities and challenges.

Critical Client Task

Alignment: Align and coordinate access and cross functional business domains; intergrade access considerations and strategy into target product profile, the clinical studies, and the regulatory, medical, marketing and commercial plans.
Capacities: Assess organisational capacities and identify the gaps between functional, regional and national level; Plan for improve capacity and skills development, across access domains; Drive creation of access mindset.
Engagement: Engage with important stakeholders in relevant pricing, reimbursement, health technology assessment, payer and governmental agencies, in academia, in professional associations, committees, and patient advocacy groups.

Services We Provide

Alignment: Enable cross functional alignment; Competition analysis and benchmarking; Advise on target product profile and clinical studies, based on market access standards; Review & advise on regulatory, medical, and marketing plans.
Capacities: Review, benchmark and assess organisational capacities; advise on business transformation and capacity building; support re-engineering; provide bespoke training to develop soft and technical skills.
Engagement: Identify and select experts and influencers in relevant agencies and organisations; develop networks and engage effectively through scientific and advocacy meetings, research, campaigns and other relevant activities aiming to establish trusted relationships.

Critical Client Task

Strategy: Develop evidence synthesis and value communication strategy. Develop strategic plans in order to support pricing, reimbursement, market access, and commercialisation, and get cross operational & functional feedback.
Planning: Develop evidence synthesis study protocols and prepare analysis plans; plan for the creation of tools to communicate effectively product value to decision makers.
Impact: Plan to shape P&R and HTA policy practices and models, in partnership with external influencers, policy experts and advocacy groups to create sustainable business environment and favourable access environment for products.

Services We Provide

Strategy: Review evidence synthesis and communication plans, related to authority evidential requirements and standards, the target product profile and competition standards, as well as advise on strategy for optimal access.
Planning: Review protocols to provide advice; Run advisory boards to receive input & internal cross functional alignment; Advise and plan value communication materials.
Impact: Policy monitoring, analysis and impact evaluation; develop corporate and therapy area policy objectives and evidence plans; expert networking, thought leadership research, scientific publications, presentations and advocacy.

Critical Client Task

Burden: Synthesise evidence on the epidemiology, the natural history, and the burden of disease and highlight its stakeholder, such as patients, payers, health care providers, impact that should concern decision makers.
Practice: Synthesise evidence on the management of patients, treatment pathways, real world product utilisation and place within treatment paradigms and guidelines.
Unmet Need: Synthesise evidence on the performance and outcomes of therapies such as safety, efficacy, effectiveness, quality of life, cost-effectiveness, compliance, dosing, mode of delivery, in order to identify unmet therapeutic needs.
Humanistic Value: Synthesise evidence on safety, efficacy, effectiveness, and impact on patient outcomes, preference, and experience of new products, to prove their incremental clinical and humanistic value to decision makers deciding on pricing and coverage.
Economic Value: Deliver early economic models for the internal assessment of new products; late economic models to demonstrate to payers the value for money and the budget impact of new products; assess impact and the external value of innovative agreements.
Value Communication: Present and communicate product value parameters, to decision makers in convincingly meaningful, relevant, and customised manner, in order to attain from them positive appraisals, pricing, reimbursement and coverage decisions.

Services We Provide

Burden: Undertake reviews, quality assessment and qualitative synthesis of published evidence, to quantify the epidemiology, history, and course of disease and its humanistic, social, medical, health care and economic burden.
Practice: Undertake reviews, quality assessment and qualitative synthesis of published evidence, on treatment practices, guidelines and therapy utilisation.
Unmet Need: Undertake targeted or systematic literature reviews and qualitative synthesis. Undertake quantitative synthesis of evidence through direct and indirect meta-analyses and quantitative assessments of evidential quality.
Humanistic Value: Undertake targeted or systematic literature reviews and qualitative synthesis and quality assessment of evidence; Undertake quantitative synthesis of evidence through direct and indirect meta-analyses and quantitative assessments.
Economic Value: Build, review, extend, update or customise for single or multiple countries cost-minimisation, cost-effectiveness, cost-utility, cost-benefit or budget impact models for internal or external use; undertake data analytics, simulation and forecasting modelling.
Value Communication: Build, review or customise value dossiers, formulary dossiers and HTA reports; produce publications, presentations, slide decks, abstracts; present to congresses; deliver interactive and customisable digital tools to communicate value and to handle objections.

Critical Client Task

Execution: Drive implementation of business strategy; Manage engagement and critical negotiations with National authorities and key accounts, in order to achieve best access at optimal price, throughout product life cycle.
Support: Train, guide, coordinate and support staff in access negotiations with stakeholders; develop tools to monitor and facilitate access and share collective intelligence and experience.

Services We Provide

Execution: Support client submissions, negotiations and tenders with tailor made analytics, reports, models, advisory work, presentations, internal workshops, and registry design for managed agreements and tenders.
Support: Undertake bespoke technical and negotiation training; coordinate and support operational implementation of strategy and plans; facilitate internal brainstorming and alignment workshops; present to stakeholders;

Value communication

Services

Value Communication Strategy and Execution.

Our 5 Steps Process for Value Communication

Critical Client Task

Services We Provide

Critical Client Task

Services We Provide

Critical Client Task

Services We Provide

Critical Client Task

Services We Provide

Critical Client Task

Services We Provide

Who we are

What we do

How we work

We are an impartial and independent market access and business development services firm, branch of Swiss Approval International, specialised in the Health Care and Life Science business.

WE'RE SOCIAL